Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sarah Chamlin

Dermatology Chicago, IL Medical Doctor

NPI 1053370890 CMS profile 229344

2300 Childrens Plaza, # 107, Chicago, IL 60614

Open in the dashboard

General payments

$134,640

178 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$280,182 paid to institutions, not to them · program years 2019–2022

Through program year 2025, Sarah Chamlin of Chicago, IL is reported in the CMS Open Payments database as having received $134,640 across 178 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $280,182 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 95th percentile of Dermatology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,601 11
2024 General $5,068 18
2023 General $12,102 38
2022 General $42,631 43
2021 General $16,616 14
2020 General $8,310 6
2019 General $48,313 48

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Chamlin
  • Dermatology median
  • Middle half of Dermatology
  • National median

In program year 2025, general payments to Sarah Chamlin were reported at $1,601. Among 10,363 Dermatology profiles paid that year, the median was $788 and the middle half received between $207 and $1,974.

Show as a table
Year Sarah Chamlin Dermatology median Middle half National median
2019 $48,313 $454 $129–$1,240 $163
2020 $8,310 $235 $81–$756 $114
2021 $16,616 $377 $108–$1,108 $132
2022 $42,631 $514 $143–$1,391 $149
2023 $12,102 $607 $159–$1,674 $160
2024 $5,068 $751 $204–$1,903 $164
2025 $1,601 $788 $207–$1,974 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Regeneron Healthcare Solutions, Inc. $67,094 78 payments
  2. Genzyme Corporation $44,827 49 payments
  3. Merck Sharp & Dohme Corporation $21,435 19 payments
  4. Pierre Fabre Pharmaceuticals, Inc. $561 5 payments
  5. Sanofi-Aventis U.S. LLC $273 11 payments
  6. Pfizer Inc. $125 3 payments
  7. Incyte Corporation $75 3 payments
  8. AbbVie, Inc. $70 3 payments
  9. Nobelpharma America, LLC $45 2 payments
  10. Arcutis Biotherapeutics, Inc. $41 1 payment
  11. Other $92 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $77,797 31 payments
  2. Consulting Fee $45,948 28 payments
  3. Travel and Lodging $7,723 35 payments
  4. Food and Beverage $3,157 83 payments
  5. Education $15 1 payment
Products named General payments · program years 2019–2025
  1. DUPIXENT Inflammation And Immunology $67,094 78 payments
  2. DUPIXENT Immunology $62,307 68 payments
  3. DUPIXENT Immunology $7,774 11 payments
  4. ENFLONSIA $1,220 2 payments
  5. HEMANGEOL $561 5 payments
  6. CIBINQO $125 3 payments
  7. LITFULO $110 2 payments
  8. OPZELURA $75 3 payments
  9. RINVOQ $70 3 payments
  10. Otezla $29 1 payment
  11. Other $86 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

178 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dermatology in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record